KEY TAKEAWAYSGrocery-store chain Kroger is selling its specialty pharmacy business to U.S. health insurer Elevance Health.Kroger didn’t disclose financial details of the deal, which it said is expected to close in the second half of 2024.The deal comes after the Federal Trade Commission last month sued to block the merger between Kroger and Albertsons. Grocery-store chain  Kroger (KR) is selling its specialty pharmacy business to U.S. health insurer Elevance Health (ELV). Kroger didn’t disclose the financia ...

Grocery store operator The Kroger Company plans to sell its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health.Kroger has entered into a definitive agreement for the sale, the company said in a Monday (March 18) press release. Subject to customary closing conditions and regulatory approvals, the sale is expected to close in the second half.“As part of our regular review of assets, it became clear that our strong specialty pharmacy business unit will better meet its full potential outs ...

Elevance Health, Inc. (ELV) is strategically poised for growth, driven by increasing memberships in individual commercial risk-based businesses and Blue Card businesses. Improving performance in the Carelon Services business is a significant tailwind for the company.Elevance, with a market capitalization of $118.6 billion, is a major health benefits company in the United States. Due to solid prospects, this currently Zacks Rank #2 (Buy) stock is worth investing in at the moment. In this analysis, we'll expl ...

Elevance Health (ELV) closed the latest trading day at $510.57, indicating a +0.21% change from the previous session's end. The stock exceeded the S&P 500, which registered a loss of 0.29% for the day. Meanwhile, the Dow experienced a drop of 0.35%, and the technology-dominated Nasdaq saw a decrease of 0.3%.The health insurer's stock has climbed by 0.67% in the past month, falling short of the Medical sector's gain of 3.72% and the S&P 500's gain of 4.42%.The investment community will be closely monitoring ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Elevance Health (ELV) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Elevance Health currently has an average brokerage recomm ...

Elevance Health, Inc. (ELV) recently announced that it has completed the acquisition of Paragon Healthcare, Inc., the agreement for which was made public in the first week of this year. The strategic move is aimed at boosting its capabilities in multi-site infusion services and specialty pharmacy.Earlier, Reuters reported that the acquisition would cost ELV more than $1 billion, according to an Axios report. The acquisition is expected to help the company offer affordable and convenient healthcare solutions ...

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. Paragon Healthcare provides infusion services to patients through its omnichannel model of ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services. The company, headquartered in Plano, Texas, currently serves more than 35,000 patients at over 40 a ...

nortonrsx/iStock via Getty Images Elevance Health, Inc. (NYSE:ELV) reported strong financial growth in Q4 and full year 2023 with the increase in revenues and earnings per share. This growth was driven by the uptick in premium and product revenues. The company also showed growth in net income in 2023, despite the increase in total expenses. This article presents the financial metrics of Elevance Health, strategic contribution of different segments and technical analysis based on the historical trends. I ...

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings ...

It has been about a month since the last earnings report for Elevance Health (ELV) . Shares have added about 6.6% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Elevance Health due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Elevance Health Q4 Earnings Beat on Pr ...